SOM230, 300micrograms ( DrugBank: - )

1 disease

ID	Disease name (Link within this page)	Number of trials
75	Cushing disease	1

75. Cushing disease

Clinical trials : 205 / Drugs : 176 - (DrugBank : 45) / Drug target genes : 61 - Drug target pathways : 127

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2012-002916-16-DE (EUCTR)	19/08/2014	17/03/2014	Study of management of pasireotide-induced hyperglycemia in adult patients with Cushing’s disease or ...	A multi-center, randomized, open-label, Phase IV study to investigate the management of pasireotide- ...	Cushing's disease and acromegaly MedDRA version: 19.0;Level: LLT;Classification code 10011651;Term: ...	Trade Name: Signifor Product Name: pasireotide Product Code: SOM230, 300micrograms INN or Proposed INN: ...	Novartis Pharma Services AG	NULL	Not Recruiting			Female: yes Male: yes	133	Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): no Therapeutic confirmatory - (P ...	United States;Belgium;Poland;Turkey;Denmark;Russian Federation;Germany;China

First Previous1Next Last